Found 105 matching trials
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC N/A Multi-center observational clinical study to evaluate the application value...
Show More Location
Parc de Salut Mar - Hospital del Mar
Learn More & Join Trial
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy N/A This Observational study will explore the utility of the Biodesix, Inc. "PI...
Show More Location
Addario Lung Cancer Medical Institute (ALCMI)
Learn More & Join Trial
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma PHASE1 This study will assess the immunomodulatory activity of entinostat in patie...
Show More Location
Indiana University Health Hospital
Learn More & Join Trial
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519) N/A This is a multicenter, non-interventional, retrospective study (with two pr...
Show More Location
N.N. Blokhin Russian Cancer Research Center
Learn More & Join Trial
Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme PHASE1 CAR T cell immunotherapy has achieved great success in CD19+ B-cell maligna...
Show More Location
Sanbo Brain Hospital Capital Medical University
Learn More & Join Trial
Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC PHASE2 This study is to determine if Healthy Donor FMT (hdFMT) improves the body's...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer NA This is a prospective pilot study to assess dynamic changes of plasma cell-...
Show More Location
Ballad Health Cancer Care
Learn More & Join Trial
Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests NA Multiple myeloma (MM) is the most common bone marrow malignancy of terminal...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors PHASE1 The purpose of this study is to determine the safety, feasibility, recommen...
Show More Location
NYU Langone Health
Learn More & Join Trial
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) PHASE1 This study consists of several parts: dose escalation, dose expansion, dose...
Show More Location
University of California at San Francisco ( Site 0004)
Learn More & Join Trial